Arkolith/Insider Trading/TLSI/Form 4

Szela Mary T

CEO and President, DirectorTriSalus Life Sciences, Inc. (TLSI) · full profile →Form 4 · filed Nov 25, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 24, 2025Grant(A)300K—$0743K
Nov 24, 2025Grant(A)125K—$0443K
Feb 13, 2024Grant(A)125K—$0318K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 24, 2025Grant(A)250K—$01.6M

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001410289-25-000006) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML